Skip to main content
BLLN
NASDAQ Life Sciences

BillionToOne Rejects Short Seller's Claims, Weighs Legal Action

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$91.54
Mkt Cap
$4.373B
52W Low
$61.96
52W High
$150.44
52W Position info
48% above low
Off High info
39% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

BLLN sits 48% above its 52-week low of $61.96 on elevated volume (2.3× avg).

Summary

BillionToOne formally rejected Fuzzy Panda Research's November 18 short report, calling its claims inaccurate, distorted and reliant on anonymous sources and selectively presented data. The company said it is reviewing the report with legal advisors and considering all available legal options. This is the company's first substantive rebuttal after shares fell 10% on the report earlier today. The response defends billing, patient financial assistance and commercial practices as compliant, and CEO Oguzhan Atay stood behind the company's testing and disclosures. The rebuttal contains no new financial figures or operational disclosures, so it addresses reputation and legal risk rather than the underlying business.

At the time of this announcement, BLLN was trading at $91.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $61.96 to $150.44. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

BLLN - Latest Insights

BLLN
Nov 18, 2026, 9:38 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $87.83
Real-time Price: $91.54 info
Change: +$3.71 (+4%) info
Market Cap: $4.373B info
BLLN
Nov 04, 2026, 4:47 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.00
Real-time Price: $91.54 info
Change: -$21.46 (-19%) info
Market Cap: $4.373B info
BLLN
Nov 04, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $119.49
Real-time Price: $91.54 info
Change: -$27.95 (-23%) info
Market Cap: $4.373B info
BLLN
Oct 07, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $99.87
Real-time Price: $91.54 info
Change: -$8.33 (-8%) info
Market Cap: $4.373B info
BLLN
Aug 05, 2026, 4:42 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $113.35
Real-time Price: $91.54 info
Change: -$21.81 (-19%) info
Market Cap: $4.373B info